| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions |
| 10/03/2006 | CA2205906C In-vivo diagnostic process by near infrared radiation |
| 09/28/2006 | WO2006102007A2 Methods for synthesizing alkylated and alkenylated quinone derivatives |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006101016A1 Composite material, light emitting element and light emitting device |
| 09/28/2006 | WO2006100686A1 Novel polymorph form g of fluvastatin sodium and process for the preparation thereof |
| 09/28/2006 | WO2006100519A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | WO2006100479A1 Methods for the synthesis of heteroaromatic compounds |
| 09/28/2006 | WO2006100208A1 1-benzylindole-2-carboxamide derivatives |
| 09/28/2006 | WO2006100168A1 Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives |
| 09/28/2006 | WO2006100100A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 09/28/2006 | WO2006100082A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2006 | WO2006099684A1 Copper complexes |
| 09/28/2006 | WO2006099677A1 Metal complexes |
| 09/28/2006 | WO2006083407A3 Method to prepare bis(halophthalimides) |
| 09/28/2006 | WO2006055725A3 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 09/28/2006 | WO2006050451A3 Methods and compositions to treat motor neuron disease |
| 09/28/2006 | WO2006044975A3 Compositions and their use as anti-tumor agents |
| 09/28/2006 | WO2005080329A3 Process for manufacture of racemic carvedilol |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217432 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | DE102005014628A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders |
| 09/28/2006 | CA2602194A1 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof |
| 09/28/2006 | CA2602003A1 Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives |
| 09/28/2006 | CA2601401A1 Novel polymorph form g of fluvastatin sodium and process for the preparation thereof |
| 09/28/2006 | CA2601000A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 09/28/2006 | CA2599855A1 1-benzylindole-2-carboxamide derivatives |
| 09/28/2006 | CA2599436A1 Mitotic kinesin inhibitors |
| 09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | CA2598205A1 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1704150A1 2,3-dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/27/2006 | EP1703905A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | CN1839147A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 09/27/2006 | CN1839116A Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 09/27/2006 | CN1837194A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 09/27/2006 | CN1837193A Process for preparing diindolylmethane derivatives |
| 09/27/2006 | CN1276922C Metal phthalocyanine derivative, salt and preparing method thereof |
| 09/27/2006 | CN1276921C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 09/26/2006 | US7112682 intermediates for N-alkylamino indoles; amination of indoles with hydroxylamine-O-sulfonic acid using organic base, aprotic solvent to form N-amino-indoles; condensation with ketone to form hydrazone; N-(n-propyl)-N-(3-fluoro-4-pyridinyl)-1H-3-methyl-indol-1-amine; large scale; by-product inhibition |
| 09/26/2006 | US7112674 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112602 Methods of treating undesired angiogenesis with 2-methyl-EM-138 |
| 09/26/2006 | US7112594 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents |
| 09/26/2006 | US7112586 Substituted diamine derivatives useful as motilin antagonists |
| 09/26/2006 | US7112391 Electrophotographic organophotoreceptors with novel charge transport compounds |
| 09/21/2006 | WO2006099416A1 2-methyl indole cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/21/2006 | WO2006099077A1 Novel crystalline forms of antidiabetic compounds |
| 09/21/2006 | WO2006098884A1 Indole derivatives and methods of using the same |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | WO2006097941A1 An improved process for the purification of perindopril |
| 09/21/2006 | WO2006097809A2 Novel tyrosine derivatives |
| 09/21/2006 | WO2006096911A1 Novel potassium channel blockers and uses thereof |
| 09/21/2006 | WO2006060456A3 Indole derivatives for use as ppar ppar active compounds |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | US20060211892 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 09/21/2006 | US20060211867 Process for the preparation of perindopril |
| 09/21/2006 | US20060211760 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/21/2006 | US20060211758 M3 muscarinic acetylcholine receptor antagonists |
| 09/21/2006 | US20060211757 Inhibitors of murine double minute-2(mdm2) such as (2'r,3's,4'r,5'r)6-chloro-4'-2,2-dimethyl-propyl-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro[indole-3,3'-pyrrolidine]-5'-carboxylic acid(3-morpholin-4-yl-propyl)-amide, used for inducing apoptosis and cell cycle arrest; antiproliferative agents |
| 09/21/2006 | US20060211740 Novel compounds |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | US20060211045 Fluorescently tagged ligands |
| 09/21/2006 | US20060210896 Aromatic amine-based charge transport materials having an N,N-divinyl group |
| 09/21/2006 | US20060208235 Chromophores have utility as photo-polymerization initiators and two-photon fluorophores for biological imaging |
| 09/21/2006 | DE102005012771A1 Verfahren zur Herstellung von 2-Azabicyclo(3.3.0)octan-3-carbonsäurederivaten A process for producing 2-azabicyclo (3.3.0) octane-3-carboxylic acid derivatives |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | CA2601884A1 Novel tyrosine derivatives |
| 09/21/2006 | CA2601647A1 An improved process for the purification of perindopril |
| 09/21/2006 | CA2599710A1 Novel crystalline forms of antidiabetic compounds |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701940A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 09/20/2006 | EP1701718A2 Substituted melatonin derivatives, process for their preparation, and methods of use |
| 09/20/2006 | EP1301520B1 Ligands, complex compounds and their use for polymerising olefins |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1835966A Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 09/20/2006 | CN1835965A Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/20/2006 | CN1835913A Propionic acid derivatives useful in the treatment of lipid disorders |
| 09/20/2006 | CN1834097A Method of producing 10-hydroxy camptothein |
| 09/20/2006 | CN1834089A Prepn. of 3-position substituted indole derivative |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275965C Derivatives of variolin b |
| 09/20/2006 | CN1275942C Benzyloxy substituted indole compound and its analog and their production method and application |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109350 Process for the preparation of optically active amines or salts thereof |
| 09/19/2006 | US7109314 Fluorescent nucleotides |